Dynavax to Report Third Quarter 2009 Financial Results after Market Closes on October 22, 2009
October 21 2009 - 4:36PM
Business Wire
Dynavax Technologies Corporation (NASDAQ: DVAX) announced today
that it plans to report third quarter 2009 financial results after
the market closes on Thursday, October 22, 2009.
The Company also plans to host a webcast of a conference call on
Thursday, October 22, 2009 at 4:30 pm EDT (1:30 pm PDT). To access
the live audio webcast and the subsequent archived audio recording
of the presentation, please log onto Dynavax’s website at
http://investors.dynavax.com/newsevents.cfm.
About Dynavax
Dynavax Technologies Corporation, a clinical-stage
biopharmaceutical company, discovers and develops novel products to
prevent and treat infectious diseases. The Company's lead product
candidate is HEPLISAVTM, a Phase 3 investigational adult hepatitis
B vaccine designed to provide more rapid and increased protection
with fewer doses than current licensed vaccines. For more
information visit www.dynavax.com.
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From May 2023 to May 2024